EileenLagathu

Counsel

Paris + 33.1.56.59.39.32

Plus de 10 ans de pratique ont permis à Eileen Lagathu d’acquérir une expérience significative des différentes facettes du droit de la concurrence européen et français, tant en matière de contrôle des concentrations que d’aides d’Etat et d’enquêtes pour cartels de la Commission européenne ou de l’Autorité de la concurrence. Elle a également représenté des clients dans de nombreux contentieux devant le Tribunal et la Cour de Justice de l’UE, ainsi que devant la Cour d’appel de Paris, dans des affaires emblématiques, qui ont contribué à façonner la jurisprudence relative aux amendes.

Eileen Lagathu accompagne quotidiennement les clients dans l’élaboration de leurs contrats commerciaux, notamment des accords de R&D ou d’exclusivité, et plus généralement, dans la structuration de leurs réseaux de distribution. Elle les aide également à mettre en place des mesures de conformité. Elle conseille également des multinationales sur les questions de contrôle des concentrations soulevées par leurs transactions (cessions d’actifs, de titres, créations de JV). Elle travaille régulièrement sur des notifications à la Commission européenne ou à l’Autorité de la concurrence, et la coordination de notifications multi-juridictionnelles.

Elle représente régulièrement des clients dans les secteurs énergétique, pharmaceutique, bancaire et financier, ce qui lui a permis d’acquérir une compréhension approfondie de ces domaines.

Eileen Lagathu a une connaissance particulièrement développée en matière d’amendes, en sa qualité de co-auteur, depuis 2013, de l’étude annuelle : Law on Fines Imposed in EU Competition Proceedings, publiée par la revue JECLAP (Oxford Academic).

Expérience

  • Simpson Manufacturing Company announces offer to acquire Etanco GroupJones Day is advising Simpson Manufacturing Company, Inc. in the €725 million binding offer with exclusivity to acquire the Etanco Group.
  • Sanofi sells 10 established products to CheplapharmJones Day is advising Sanofi in the sale of a portfolio of pharmaceutical products to Cheplapharm Arzneimittel GmbH, a German privately-owned company headquartered in Greifswald, Germany.
  • Sanofi divests 16 brands to STADAJones Day advised Sanofi in the sale of 16 Consumer Healthcare products commercialized in Europe to STADA Arzneimittel AG.
  • Sanofi sells anti-inflammatory drugs to Fidia FarmaceuticiJones Day advised Sanofi in the sale of a portfolio of pharmaceutical products to Fidia Farmaceutici.
  • Reno De Medici sells 100% interest in R.D.M. La Rochette S.A.S.Jones Day advised Reno De Medici SpA in the sale of its 100% interest in R.D.M. La Rochette S.A.S. to La Rochette Holding S.A.S., 100% owned by Mutares SE & Co. KgaA.
  • Expropriated SNS Reaal bondholders secure compensation from Dutch StateJones Day successfully assisted SNS Reaal bondholders in obtaining a judgment securing €804 million in compensation from the Dutch State for the nationalization of SNS Reaal NV and SNS Bank NV on February 1, 2013.
  • Sanofi sold Effortil (Etilefrin) pharmaceuticals products to SERB SAJones Day advised Sanofi in the sale of the Effortil (Etilefrin) pharmaceuticals products to SERB SA.
  • Total acquires Fonroche BiogazJones Day advised Total in the acquisition of Fonroche Biogaz, a company that designs, builds and operates anaerobic digestion units in France.
  • IFPEN prevails in State aid case against EU CommissionJones Day client IFP Énergies nouvelles (IFPEN) secured an important victory when the EU General Court in Luxembourg annulled, for the second time, a European Commission decision finding that IFPEN had received State aid linked to its public legal status.
  • Natural products company addresses labor and employment aspects of multijurisdictional litigation, data protection, and DIRECCTE mattersJones Day is advising a leading U.S.-based natural products company on the labor and employment aspects for a variety of multijurisdictional matters, including labor law advice on hiring and termination of employees in Belgium; matters related to collaboration with independent contractors, including litigation; data protection matters for various affiliates of the client in Belgium, the Netherlands, Denmark, Finland, Norway, Sweden, Switzerland and UAE; as well as advising on administrative/competition law-related procedures against French governmental institution DIRECCTE (Regional Offices for Commerce, Competition, Consumption, Labour and Employment).
  • Sanofi sold Lepticur to Laboratoires DelbertJones Day advised Sanofi in the sale of Lepticur to Laboratoires Delbert.
  • Sanofi sold two product portfolios to CHEPLAPHARMJones Day advised Sanofi in the sale of a portfolio of pharmaceuticals products to CHEPLAPHARM Arzneimittel GmbH.
  • EcoVadis raises $200 million in Series B roundJones Day assisted EcoVadis SAS, a provider of environmental, social, and ethical performance ratings for global supply chains, in connection with their $200 million Series B round of financing led by CVC Growth Partners.
  • Total Quadran sold 50% stake in two holding companies holding wind and solar assets in France to la Caisse des Dépôts et ConsignationsJones Day advised Total Quadran in the sale by the Quadran group, which is part of the Total group, of a 50% stake in two holding companies holding a portfolio of wind and solar assets in France, to la Caisse des Dépôts et Consignations.
  • Société Générale sold SKB Banka (Slovenia) and its subsidiaries to OTP BankJones Day advised Société Générale in the sale to OTP Bank Nyrt. of its shareholding in the share capital of its subsidiary specializing in retail banking, SKB Banka d.d. Ljubljana (Slovenia), and of its subsidiaries SKB Leasing d.o.o. and SKB Leasing Select d.o.o.
  • Société Générale sold Ohridska Banka (Macedonia) to Steiermärkische Bank und Sparkassen AGJones Day advised Société Générale in the sale of majority stake in Ohridska Banka AD Skopje (Republic of North Macedonia) to Steiermärkische Bank und Sparkassen AG.
  • Société Générale sells Societe Generale Serbia and Sogelease Serbia to OTP BankJones Day advised Société Générale in the sale of 100% of the shares in its subsidiary Societe Generale Serbia (SGS) and Sogelease Serbia to OTP Bank Nyrt., including the indirect sale of 100% of the shares in SG Leasing (SGS' wholly owned subsidiary dedicated to leasing activities).
  • Société Générale sells its majority stake in Mobiasbanca Societe Generale (Moldova) to OTP BankJones Day advised Société Générale in the sale of its majority stake in Mobiasbanca Societe Generale (Moldova) to OTP Bank Nyrt, the leading Hungarian bank.
  • Société Générale sells Societe Generale Montenegro to OTP BankJones Day advised Société Générale in the sale of Societe Generale Montenegro to OTP Bank.
  • Renault receives proposal to combine from FCAJones Day is advising Renault on antitrust matters in relation to its proposed combination with Fiat Chrysler Automobiles N.V. (FCA), following the non-binding letter FCA sent to the Board of Renault proposing a combination of their respective businesses as a 50/50 merger.